Castillo HE, Garibay VM, Mirabent-González JF

Language: Spanish
References: 21
Page: 373-380
PDF size: 252.24 Kb.

ABSTRACT

Background: Vulvovaginitis is one of the main causes of premature membrane rupture.
Objective: To evaluate effectiveness of a combination of ketoconazole (400 mg) and clindamycin (100 mg) in vaginal tablets, compared with clindamicyn alone (600 mg/daily) orally, for six days, to prevent premature membrane rupture in patients with vulvovaginitis.
Patients and method: Longitudinal, prospective, comparative, randomized, double-blind, double-dummy study in patients older than 18 years, during them third trimester of normoevolutive pregnancy with symptomatic vulvovaginitis. Patients were monitored as out patient. Genital secretion culture and fresh studies were made. Signs and symptoms were evaluated in regular intervals: 4, 7 and 11 days. Pregnancy control was performed every three weeks, until childbirth or premature membrane rupture.
Results: 105 patients were included: 53 in the group of ketoconazole and clindamicyn (1), and 52 in the group of clindamycin alone (2). Symptoms were similar in both groups of treatment, without statistically significant differences. A case of group 2 has premature membrane rupture (p = 0.495). C. albicans was cultured in 35% of group 2 and in 11% of group 2. No adverse events with treatments were reported.
Conclusions: The combination of ketoconazole and cindamycin was effective to prevent premature membrane rupture in patients with vulvovaginitis.

REFERENCES

1. Althabe F, Carroli G, Lede R, Belizán JM, Althabe OH. El parto pretérmino: detección de riesgos y tratamientos preventivos. Rev Panam Salud Pública 1999;5(6):373-85.

2. Mattison DR, Damus K. Preterm delivery: a public health perspective. Pediatr Perinat Epidemiol 2001;15(Suppl 2):7-16.

3. Goldenberg RL, Hauth JC. Intrauterine infection and preterm delivery. N Eng J Med 2000;342(20):1500-7.

4. Faro S. Enfermedades infecciosas en la mujer. 1a ed. México: Mc Graw Hill Interamericana.

5. Sobel JD. Overview of vaginitis. In: Rose DB (ed.), UpToDate (CD-ROM). Wellesley: UpToDate, Inc. 2000.

6. Blanco LS. Ruptura prematura de membranas. Dirección URL:.

7. Harrison H. Intrauterine infection and preterm delivery. Prematury Research. Dirección URL:

8. Cueto C, Oliver RA. Densidad de colonización vaginal por estreptococo del grupo B y rotura prematura de membranas. Clin Invest Gin Obstet 1999;26(7):278-81.

9. Messalli EM, Galano C. Correlazione tra vaginosi e rottura prematura delle membrane. Arch Ostet Ginecol 1999;8(4):77-78.

10. Miranda JA, Herruzo AJ. Vaginosis bacteriana en obstetricia. Prog Obstet Ginecol 1996;39(8)559-70.

11. Mercer BM, Goldenberg RL. The preterm prediction study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 2000;183(3):738-45.

12. McGregor JA. French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000;55(Suppl 1):S1-S19.

13. Govender L, Hoosen AA. Bacterial vaginosis and associated infections in pregnancy. Int J Gynecol Obstet 1996;55(1):23-28.

14. McCoy MC, Katz VL, Kuller JA. Bacterial vaginosis in pregnancy: an approach for the 1990. Obstet Gynecol Surv 1995;50(6):482-8.

15. McGregor JA, French JI. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol 1993;169(Suppl 2):463-6.

16. McGregor JA, French JI. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170(4):1048-60.

17. Ugwumadu A, Manyonda I. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomized controlled trial. Lancet 2003;361:983-8.

18. Thorp NJ, Hartmann KE. Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am J Obstet Gynecol 2002;186:587-92.

19. Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;5(97):643-8.

20. Gómez-Bravo TE, Garibay-Valencia M. Evaluación de la eficacia de la cobinación de ketoconazol/clindamicina comparado con metronidazol/nistatina en vaginitis candidiásica y vaginosis bacteriana. Ginecol Obstet Mex 2004;72:575-80.

21. Godinez V, Garibay M, Mirabent F, Pérez CA. Comparación de la eficacia de la combinación ketoconazol 400 mg + clindamicina 100 mg, con ketoconazol 800 mg + clindamicina 100 mg en vaginitis por Candida y vaginosis bacteriana. Ginecol Obstet Mex 2005;73:302-7.